Muhammad Rafehi

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Gestational Age

Major Depressive Disorder

Top Venues

Neural regeneration research

International journal of molecular sciences

Pharmaceutical research

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-Khalil, Sven Marcel Stefan
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical research 41 (3) (2024)
Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-Khalil, Sven Marcel Stefan
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical research 41 (3) (2024)
Jörg Haupenthal, Muhammad Rafehi, Andreas Martin Kany, Anne Lespine, Katja Stefan, Anna Katharina Herta Hirsch, Sven Marcel Stefan
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs). Archiv der Pharmazie 357 (9) (2024)
Jörg Haupenthal, Muhammad Rafehi, Andreas Martin Kany, Anne Lespine, Katja Stefan, Anna Katharina Herta Hirsch, Sven Marcel Stefan
Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs). Archiv der Pharmazie (2024)
Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-Khalil, Sven Marcel Stefan
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical research (2024)
Muhammad Rafehi, Marius Möller, Wouroud Ismail Al-Khalil, Sven Marcel Stefan
Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical research 41 (3) (2024)
Sven Marcel Stefan, Muhammad Rafehi
The big data challenge - and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural regeneration research 19 (8) (2023)
Sven Marcel Stefan, Muhammad Rafehi
The big data challenge - and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural regeneration research 19 (8) (2023)
Sven Marcel Stefan, Muhammad Rafehi
The big data challenge - and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural regeneration research 19 (8) (2023)
Sven Marcel Stefan, Muhammad Rafehi
Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development. Drug development research (2023)
Sven Marcel Stefan, Muhammad Rafehi
The big data challenge - and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural regeneration research 19 (8) (2023)
Lukas Gebauer, Ole Jensen, Muhammad Rafehi, Jürgen Brockmöller
Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3. Journal of medicinal chemistry (2023)
Lukas Gebauer, Ole Jensen, Muhammad Rafehi, Jürgen Brockmöller
Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters. Molecular pharmaceutics (2023)
Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. International journal of molecular sciences 23 (23) (2022)
Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. International journal of molecular sciences 23 (23) (2022)
Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. International journal of molecular sciences 23 (23) (2022)
Jingyun Wu, Luisa Möhle, Thomas Brüning, Iván Eiriz, Muhammad Rafehi, Katja Stefan, Sven Marcel Stefan, Jens Pahnke
A Novel Huntington's Disease Assessment Platform to Support Future Drug Discovery and Development. International journal of molecular sciences 23 (23) (2022)
Lukas Gebauer, Muhammad Rafehi, Jürgen Brockmöller
Stereoselectivity in the Membrane Transport of Phenylethylamine Derivatives by Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3. Biomolecules 12 (10) (2022)
Markus Kuschak, Vigneshwaran Namasivayam, Muhammad Rafehi, Jan Hendrik Voß, Jaspal Garg, Jonathan G Schlegel, Aliaa Abdelrahman, Stefan Kehraus, Raphael Reher, Jim Küppers, Katharina Sylvester, Sonja Hinz, Michaela Matthey, Daniela Wenzel, Bernd K Fleischmann, Alexander Pfeifer, Asuka Inoue, Michael Gütschow, Gabriele M König, Christa Elisabeth Müller
Cell-permeable high-affinity tracers for Gq proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitors. British journal of pharmacology 177 (8) (2020)
Younis Baqi, Thanigaimalai Pillaiyar, Aliaa Abdelrahman, Olesja Kaufmann, Samer Alshaibani, Muhammad Rafehi, Saman Ghasimi, Rhalid Akkari, Kirsten Ritter, Katharina Simon, Andreas Spinrath, Evi Kostenis, Qiang Zhao, Meryem Köse, Vigneshwaran Namasivayam, Christa Elisabeth Müller
3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17. Journal of medicinal chemistry 61 (18) (2018)
Muhammad Rafehi, Alexander Neumann, Younis Baqi, Enas M Malik, Michael Wiese, Vigneshwaran Namasivayam, Christa Elisabeth Müller
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor. Journal of medicinal chemistry 60 (20) (2017)